CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
allogeneic hematopoietic stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid...
Phase 3
Gilbert, Arizona, United States and 23 other locations
Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...
Phase 3
Gilbert, Arizona, United States and 114 other locations
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
Phoenix, Arizona, United States and 89 other locations
Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...
Phase 1
Phoenix, Arizona, United States and 43 other locations
will be evaluated in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML). The main study has ...
Phase 1, Phase 2
Gilbert, Arizona, United States and 43 other locations
The purpose of this study is to assess if adding revumenib to standard chemotherapy improves outcomes in participants with AML with certain ...
Phase 3
Goodyear, Arizona, United States and 148 other locations
This is a two Part study in patients with relapsed/refractory acute myeloid leukemia (AML), chronic myelomonocyti...
Phase 1, Phase 2
Gilbert, Arizona, United States and 7 other locations
VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...
Phase 3
Goodyear, Arizona, United States and 265 other locations
This is a multi-center, randomized, double-blinded, placebo controlled trial.
Phase 3
Gilbert, Arizona, United States and 111 other locations
profile of CTX-712 in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML) and higher risk myelod...
Phase 1, Phase 2
Phoenix, Arizona, United States and 7 other locations
Clinical trials
Research sites
Resources
Legal